少关节型银屑病关节炎：应对一种有趣表型中的临床挑战
Oligoarticular Psoriatic Arthritis: Addressing Clinical Challenges in an Intriguing Phenotype.
作者信息
Marchesoni Antonio
机构信息
ASST Gaetano Pini-CTO, Milan, Italy.
出版信息
Rheumatol Ther. 2018 Dec;5(2):311-316. doi: 10.1007/s40744-018-0115-5. Epub 2018 Jun 1.
Abstract
Details continue to emerge on psoriatic arthritis, expanding our understanding of its pathogenesis and clinical features. This has led to the evolution of management guidelines, which now recognize additional disease manifestations. In this rapidly changing area, it is timely to review the latest evidence and discuss whether management strategies are meeting patients' needs. FUNDING: Celgene Corporation.
摘要
银屑病关节炎的细节不断浮现，加深了我们对其发病机制和临床特征的理解。这促使管理指南不断演变，如今已认识到更多的疾病表现。在这个快速变化的领域，及时回顾最新证据并讨论管理策略是否满足患者需求很有必要。资助：新基公司。
相似文献
1
Oligoarticular Psoriatic Arthritis: Addressing Clinical Challenges in an Intriguing Phenotype.少关节型银屑病关节炎：应对一种有趣表型中的临床挑战
Rheumatol Ther. 2018 Dec;5(2):311-316. doi: 10.1007/s40744-018-0115-5. Epub 2018 Jun 1.
2
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.银屑病和银屑病关节炎管理的护理指南：第2节。银屑病关节炎：概述及以生物制剂为重点的治疗护理指南。
J Am Acad Dermatol. 2008 May;58(5):851-64. doi: 10.1016/j.jaad.2008.02.040.
3
The pathogenesis of psoriatic arthritis.银屑病关节炎的发病机制。
Lancet. 2018 Jun 2;391(10136):2273-2284. doi: 10.1016/S0140-6736(18)30830-4. Epub 2018 Jun 1.
4
Psoriatic arthritis as a distinct disease entity.
J Postgrad Med. 2007 Jan-Mar;53(1):63-71. doi: 10.4103/0022-3859.30334.
5
Psoriatic arthritis under a proteomic spotlight: application of novel technologies to advance diagnosis and management.在蛋白质组学的聚光灯下观察银屑病关节炎：应用新技术推进诊断和管理。
Curr Rheumatol Rep. 2015 May;17(5):35. doi: 10.1007/s11926-015-0509-0.
6
Psoriatic Arthritis and Burden of Disease: Patient Perspectives from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.银屑病关节炎与疾病负担：基于人群的银屑病和银屑病关节炎多国评估（MAPP）调查中的患者观点
Rheumatol Ther. 2016 Jun;3(1):91-102. doi: 10.1007/s40744-016-0029-z. Epub 2016 Feb 29.
7
Treatment strategies for psoriatic arthritis.治疗银屑病关节炎的策略。
Joint Bone Spine. 2018 Oct;85(5):537-544. doi: 10.1016/j.jbspin.2017.11.001. Epub 2017 Nov 16.
8
Bridging the Gaps in the Care of Psoriasis and Psoriatic Arthritis: the Role of Combined Clinics.弥合银屑病和银屑病关节炎护理中的差距：联合诊所的作用。
Curr Rheumatol Rep. 2018 Oct 26;20(12):76. doi: 10.1007/s11926-018-0785-6.
9
Diagnosis and treatment of psoriatic arthritis.银屑病关节炎的诊断与治疗
J Am Acad Dermatol. 2005 Jan;52(1):1-19. doi: 10.1016/j.jaad.2004.06.013.
10
Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they?青少年银屑病关节炎患者与非银屑病青少年特发性关节炎患者的比较：他们有多大差异？
J Rheumatol. 2009 Sep;36(9):2033-41. doi: 10.3899/jrheum.080674. Epub 2009 Jul 31.
引用本文的文献
1
Baseline Ultrasound Assessment Improves the Response to Apremilast in Patients with Psoriatic Arthritis: Results from a Multicentre Study.基线超声评估可改善银屑病关节炎患者对阿普米司特的反应：一项多中心研究的结果
Mediterr J Rheumatol. 2024 Dec 31;35(4):639-644. doi: 10.31138/mjr.271223.bua. eCollection 2024 Dec.
2
Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis.寡关节型银屑病关节炎患者中白细胞介素-17的抑制作用
Rheumatol Ther. 2023 Aug;10(4):849-860. doi: 10.1007/s40744-023-00548-y. Epub 2023 May 6.
本文引用的文献
1
Considerations for the definition of remission criteria in psoriatic arthritis.考虑到银屑病关节炎缓解标准的定义。
Semin Arthritis Rheum. 2018 Jun;47(6):786-796. doi: 10.1016/j.semarthrit.2017.10.021. Epub 2017 Oct 31.
2
Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology.意大利风湿病学会2017年更新：生物制剂及其他新型药物用于治疗银屑病关节炎的推荐意见
Clin Exp Rheumatol. 2017 Nov-Dec;35(6):991-1010. Epub 2017 Nov 28.
3
Current concepts and unmet needs in psoriatic arthritis.当前银屑病关节炎的概念和未满足的需求。
Clin Rheumatol. 2018 Feb;37(2):297-305. doi: 10.1007/s10067-017-3908-y. Epub 2017 Nov 13.
4
Psoriatic arthritis: new evidence for old concepts.银屑病关节炎：旧概念的新证据。
Curr Opin Rheumatol. 2018 Jan;30(1):87-93. doi: 10.1097/BOR.0000000000000468.
5
Residual disease activity and treatment adjustments in psoriatic arthritis in current clinical practice.当前临床实践中的银屑病关节炎的残留疾病活动和治疗调整。
Arthritis Res Ther. 2017 Oct 10;19(1):226. doi: 10.1186/s13075-017-1424-8.
6
The dynamics of response as measured by multiple composite outcome tools in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial.多项综合结局工具评估的 TICOPA 试验中早期银屑病关节炎炎症严密控制的反应动力学。
Ann Rheum Dis. 2017 Oct;76(10):1688-1692. doi: 10.1136/annrheumdis-2017-211137. Epub 2017 Jun 12.
7
Cost-Effectiveness of Tight Control of Inflammation in Early Psoriatic Arthritis: Economic Analysis of a Multicenter Randomized Controlled Trial.早期银屑病关节炎炎症的严格控制的成本效益：一项多中心随机对照试验的经济学分析。
Arthritis Care Res (Hoboken). 2018 Mar;70(3):462-468. doi: 10.1002/acr.23293. Epub 2018 Jan 30.
8
The problem in differentiation between psoriatic-related polyenthesitis and fibromyalgia.银屑病相关多附着点炎与纤维肌痛的鉴别诊断问题。
Rheumatology (Oxford). 2018 Jan 1;57(1):32-40. doi: 10.1093/rheumatology/kex079.
9
Psoriatic Arthritis.银屑病关节炎
N Engl J Med. 2017 Mar 9;376(10):957-970. doi: 10.1056/NEJMra1505557.
10
Psoriatic Arthritis and Burden of Disease: Patient Perspectives from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.银屑病关节炎与疾病负担：基于人群的银屑病和银屑病关节炎多国评估（MAPP）调查中的患者观点
Rheumatol Ther. 2016 Jun;3(1):91-102. doi: 10.1007/s40744-016-0029-z. Epub 2016 Feb 29.
Zotero 插件